sjwilliamspa | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

About: Stephen Williams

Website
Details

Posts by Stephen Williams:

December 13, 2022 Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software
December 12, 2022 Science Has A Systemic Problem, Not an Innovation Problem
October 11, 2022 Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners
October 11, 2022 The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells
October 4, 2022 Cancer Policy Related News from Washington DC and New NCI Appointments
October 4, 2022 Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation
August 5, 2022 Near Term Investment Outlook for 2023: A Perspective from Advisors Potentially Affecting M&A Landscape
June 14, 2022 The Human Genome Gets Fully Sequenced: A Simplistic Take on Century Long Effort
April 1, 2022 Will Web 3.0 Do Away With Science 2.0? Is Science Falling Behind?
February 15, 2022 From the journal Nature: NFT, Patents, and Intellectual Property: Potential Design

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
- Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation October 4, 2022
Archives
Archives
Categories
Categories
Meta